🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Synovus posts EPS beat; shares hold Buy rating at Citi

Published 10/17/2024, 11:36 PM
SNV
-

On Thursday, Citi maintained a Buy rating on Synovus Financial (NYSE:SNV) with a steady price target of $53.00.

The endorsement came after the company reported third-quarter earnings that surpassed consensus expectations. Synovus Financial announced a core earnings per share (EPS) of $1.23, higher than the anticipated $1.08 by analysts. The performance was attributed to a reduction in core expenses and a lower-than-expected loan loss provision (LLP) expense.

The bank's net interest margin (NIM) trends exceeded forecasts, which was a positive development for spread revenue despite limited growth. Both net interest income (NII) revenue and fee income contributed to the core revenue, exceeding consensus expectations. These results were further bolstered by a core expense base that was smaller than anticipated.

Synovus' updated guidance was received better than initially feared, according to the analyst. Commentary regarding the 2025 loan growth outlook, which was expected to be discussed during the conference call, could potentially enhance the company's narrative. The solid third-quarter results were seen as a driving factor for the stock to perform better than its peers on the day of the announcement.

The analyst's comments reflect a positive view of Synovus Financial's recent performance and future prospects. The company's ability to manage expenses and generate revenue effectively has been highlighted as a key factor in its success. The maintained price target of $53.00 by Citi suggests confidence in the continued performance of Synovus Financial's stock.

In other recent news, Synovus Financial Corp. has reported a net loss of $0.16 per share in the second quarter of 2024, primarily due to a significant loss from securities repositioning. However, the company's adjusted earnings per share rose to $1.16, with net interest income increasing by 4% and adjusted non-interest revenue climbing 9% sequentially.

Synovus has also declared quarterly dividends for its common and preferred stocks, with common stockholders receiving $0.38 per share, and holders of the Series D and E preferred stocks receiving dividends of $0.57251 and $0.52481 per share, respectively.

Keefe, Bruyette & Woods raised the price target for Synovus to $47.00, maintaining a Market Perform rating. Other firms, including DA Davidson, Piper Sandler, Truist Securities, RBC Capital Markets, and Stephens, revised their financial outlook for Synovus, citing factors such as improved revenue, asset quality, and strategic gains from the company's recent securities repositioning.

These are all recent developments that investors should consider.

InvestingPro Insights

Synovus Financial's recent performance aligns with several InvestingPro metrics and tips, providing additional context to the positive analyst outlook. The company's stock has shown significant momentum, with InvestingPro data indicating a 9.98% return over the last week and an impressive 80.67% return over the past year. This strong performance is reflected in the stock trading near its 52-week high, at 99.08% of that peak.

The company's profitability, as highlighted in the earnings report, is further supported by InvestingPro Tips. Synovus Financial has been profitable over the last twelve months, and analysts predict continued profitability this year. This aligns with the better-than-expected earnings reported in the third quarter.

Additionally, Synovus Financial has maintained dividend payments for 51 consecutive years, according to an InvestingPro Tip. This long-standing commitment to shareholder returns may contribute to investor confidence, especially with the current dividend yield standing at 3.14%.

It's worth noting that InvestingPro has 8 additional tips available for Synovus Financial, which could provide further insights for investors looking to deepen their analysis of the company's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.